2016 Q4 Form 10-Q Financial Statement
#000119312516757218 Filed on November 02, 2016
Income Statement
Concept | 2016 Q4 | 2016 Q3 | 2015 Q3 |
---|---|---|---|
Revenue | $24.89M | $58.37M | $53.84M |
YoY Change | -55.45% | 8.42% | 20.91% |
Cost Of Revenue | $4.560M | $24.89M | $23.13M |
YoY Change | -80.7% | 7.62% | 20.98% |
Gross Profit | $20.33M | $33.48M | $30.71M |
YoY Change | -36.92% | 9.02% | 20.85% |
Gross Profit Margin | 81.68% | 57.36% | 57.04% |
Selling, General & Admin | $12.15M | $19.18M | $15.55M |
YoY Change | -32.31% | 23.34% | 13.98% |
% of Gross Profit | 59.76% | 57.29% | 50.64% |
Research & Development | $2.710M | $7.261M | $6.195M |
YoY Change | -64.15% | 17.21% | 47.11% |
% of Gross Profit | 13.33% | 21.69% | 20.17% |
Depreciation & Amortization | $4.390M | $5.755M | $4.639M |
YoY Change | -9.48% | 24.06% | 64.8% |
% of Gross Profit | 21.59% | 17.19% | 15.11% |
Operating Expenses | $19.24M | $7.261M | $6.195M |
YoY Change | -36.63% | 17.21% | -65.3% |
Operating Profit | $1.090M | $1.286M | $4.325M |
YoY Change | -41.71% | -70.27% | -8.77% |
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | $120.0K | $337.0K | $28.00K |
YoY Change | -29.41% | 1103.57% | -42.86% |
Pretax Income | $1.200M | $1.623M | $4.353M |
YoY Change | -41.46% | -62.72% | -9.12% |
Income Tax | $470.0K | $461.0K | $1.739M |
% Of Pretax Income | 39.17% | 28.4% | 39.95% |
Net Earnings | -$310.0K | $1.162M | $2.614M |
YoY Change | -117.13% | -55.55% | -23.92% |
Net Earnings / Revenue | -1.25% | 1.99% | 4.86% |
Basic Earnings Per Share | $0.04 | $0.08 | |
Diluted Earnings Per Share | -$9.767K | $0.04 | $0.08 |
COMMON SHARES | |||
Basic Shares Outstanding | 31.74M shares | 31.74M shares | 31.64M shares |
Diluted Shares Outstanding | 32.11M shares | 32.03M shares |
Balance Sheet
Concept | 2016 Q4 | 2016 Q3 | 2015 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $103.2M | $100.6M | $144.8M |
YoY Change | -30.74% | -30.52% | 24.4% |
Cash & Equivalents | $49.63M | $39.82M | $67.44M |
Short-Term Investments | $53.50M | $60.70M | $77.40M |
Other Short-Term Assets | $8.694M | $7.584M | $6.649M |
YoY Change | 6.43% | 14.06% | 86.46% |
Inventory | |||
Prepaid Expenses | |||
Receivables | $44.81M | $46.17M | $33.12M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $177.4M | $173.1M | $201.7M |
YoY Change | -15.32% | -14.18% | 23.78% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $10.25M | $10.40M | $11.85M |
YoY Change | -17.85% | -12.19% | 31.53% |
Goodwill | $85.61M | $109.8M | $84.00M |
YoY Change | 3.06% | 30.71% | 96.93% |
Intangibles | |||
YoY Change | |||
Long-Term Investments | $3.300M | $3.300M | $3.700M |
YoY Change | -8.33% | -10.81% | |
Other Assets | $603.0K | $964.0K | $1.752M |
YoY Change | -34.95% | -44.98% | 78.05% |
Total Long-Term Assets | $218.6M | $221.0M | $173.0M |
YoY Change | 28.54% | 27.7% | 115.23% |
TOTAL ASSETS | |||
Total Short-Term Assets | $177.4M | $173.1M | $201.7M |
Total Long-Term Assets | $218.6M | $221.0M | $173.0M |
Total Assets | $396.0M | $394.1M | $374.7M |
YoY Change | 4.33% | 5.16% | 53.99% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $3.127M | $3.675M | $2.251M |
YoY Change | -32.26% | 63.26% | 181.73% |
Accrued Expenses | $8.146M | $10.62M | $7.672M |
YoY Change | 16.32% | 38.46% | -34.77% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $94.97M | $95.24M | $85.47M |
YoY Change | 6.61% | 11.43% | 14.83% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $1.095M | $778.0K | $766.0K |
YoY Change | 3.5% | 1.57% | 7.89% |
Total Long-Term Liabilities | $1.095M | $778.0K | $766.0K |
YoY Change | 3.5% | 1.57% | 7.89% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $94.97M | $95.24M | $85.47M |
Total Long-Term Liabilities | $1.095M | $778.0K | $766.0K |
Total Liabilities | $96.07M | $96.02M | $86.24M |
YoY Change | 6.58% | 11.34% | 14.76% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $5.346M | $5.657M | -$220.0K |
YoY Change | 236.02% | -2671.36% | -97.73% |
Common Stock | |||
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $286.1M | $286.4M | $278.8M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $396.0M | $394.1M | $374.7M |
YoY Change | 4.33% | 5.16% | 53.99% |
Cashflow Statement
Concept | 2016 Q4 | 2016 Q3 | 2015 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$310.0K | $1.162M | $2.614M |
YoY Change | -117.13% | -55.55% | -23.92% |
Depreciation, Depletion And Amortization | $4.390M | $5.755M | $4.639M |
YoY Change | -9.48% | 24.06% | 64.8% |
Cash From Operating Activities | $9.250M | $14.69M | $6.390M |
YoY Change | -1.6% | 129.89% | -2.89% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$2.850M | -$3.400M | -$3.720M |
YoY Change | -29.1% | -8.6% | 89.8% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $3.810M | -$38.93M | $6.520M |
YoY Change | -61.55% | -697.09% | -895.12% |
Cash From Investing Activities | $960.0K | -$42.34M | $2.800M |
YoY Change | -83.7% | -1612.14% | -201.08% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -390.0K | 650.0K | 3.760M |
YoY Change | -45.83% | -82.71% | 1346.15% |
NET CHANGE | |||
Cash From Operating Activities | 9.250M | 14.69M | 6.390M |
Cash From Investing Activities | 960.0K | -42.34M | 2.800M |
Cash From Financing Activities | -390.0K | 650.0K | 3.760M |
Net Change In Cash | 9.820M | -27.00M | 12.95M |
YoY Change | -32.6% | -308.49% | 218.18% |
FREE CASH FLOW | |||
Cash From Operating Activities | $9.250M | $14.69M | $6.390M |
Capital Expenditures | -$2.850M | -$3.400M | -$3.720M |
Free Cash Flow | $12.10M | $18.09M | $10.11M |
YoY Change | -9.84% | 78.93% | 18.38% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2015Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
67441000 | |
CY2015Q3 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
115000 | |
CY2016Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2028000 | |
CY2016Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2016Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
31739000 | shares |
CY2016Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
31739741 | shares |
CY2016Q3 | us-gaap |
Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
|
280759000 | |
CY2016Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
31739000 | shares |
CY2016Q3 | us-gaap |
Assets
Assets
|
394051000 | |
CY2016Q3 | us-gaap |
Assets Current
AssetsCurrent
|
173079000 | |
CY2016Q3 | us-gaap |
Accrued Royalties Current
AccruedRoyaltiesCurrent
|
13885000 | |
CY2016Q3 | us-gaap |
Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
|
15749000 | |
CY2016Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
CY2016Q3 | us-gaap |
Common Stock No Par Value
CommonStockNoParValue
|
||
CY2016Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
603000 | |
CY2016Q3 | us-gaap |
Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
|
60747000 | |
CY2016Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
39820000 | |
CY2016Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
46166000 | |
CY2016Q3 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
6735000 | |
CY2016Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3675000 | |
CY2016Q3 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
65029000 | |
CY2016Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-27000 | |
CY2016Q3 | us-gaap |
Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
|
29717000 | |
CY2016Q3 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
4909000 | |
CY2016Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
10623000 | |
CY2016Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
14038000 | |
CY2016Q3 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
7584000 | |
CY2016Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
394051000 | |
CY2016Q3 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
80771000 | |
CY2016Q3 | us-gaap |
Goodwill
Goodwill
|
109796000 | |
CY2016Q3 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
778000 | |
CY2016Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
95240000 | |
CY2016Q3 | us-gaap |
Prepaid Royalties
PrepaidRoyalties
|
16466000 | |
CY2016Q3 | us-gaap |
Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
3289000 | |
CY2016Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
964000 | |
CY2016Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
10403000 | |
CY2016Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
286389000 | |
CY2016Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
5657000 | |
CY2016Q3 | us-gaap |
Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
|
2296000 | |
CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
81995000 | |
CY2015Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
3308000 | |
CY2015Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2015Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
31647000 | shares |
CY2015Q4 | us-gaap |
Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
|
278799000 | |
CY2015Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
31647000 | shares |
CY2015Q4 | us-gaap |
Assets
Assets
|
379569000 | |
CY2015Q4 | us-gaap |
Assets Current
AssetsCurrent
|
209537000 | |
CY2015Q4 | us-gaap |
Accrued Royalties Current
AccruedRoyaltiesCurrent
|
9053000 | |
CY2015Q4 | us-gaap |
Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
|
13955000 | |
CY2015Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
75000000 | shares |
CY2015Q4 | us-gaap |
Common Stock No Par Value
CommonStockNoParValue
|
||
CY2015Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
303000 | |
CY2015Q4 | us-gaap |
Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
|
66976000 | |
CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
82010000 | |
CY2015Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
36348000 | |
CY2015Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
4350000 | |
CY2015Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
4616000 | |
CY2015Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
65098000 | |
CY2015Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-70000 | |
CY2015Q4 | us-gaap |
Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
|
24130000 | |
CY2015Q4 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
4763000 | |
CY2015Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
7003000 | |
CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
8685000 | |
CY2015Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
8169000 | |
CY2015Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
379569000 | |
CY2015Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
55966000 | |
CY2015Q4 | us-gaap |
Goodwill
Goodwill
|
83073000 | |
CY2015Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1058000 | |
CY2015Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
89078000 | |
CY2015Q4 | us-gaap |
Prepaid Royalties
PrepaidRoyalties
|
14036000 | |
CY2015Q4 | us-gaap |
Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
3640000 | |
CY2015Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
927000 | |
CY2015Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
12471000 | |
CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
280320000 | |
CY2015Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
1591000 | |
CY2015Q4 | us-gaap |
Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
|
1998000 | |
us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
3721000 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
13000 | shares | |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-14554000 | ||
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2787000 | ||
us-gaap |
Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
|
65752000 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.23 | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
12148000 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.23 | ||
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
6800000 | ||
us-gaap |
Costs And Expenses
CostsAndExpenses
|
141457000 | ||
us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.417 | pure | |
us-gaap |
Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
|
3721000 | ||
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
123000 | ||
us-gaap |
Sales Revenue Net
SalesRevenueNet
|
153136000 | ||
us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
20851000 | ||
us-gaap |
Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
|
946000 | ||
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-7000 | ||
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
3082000 | ||
us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-10000 | ||
us-gaap |
Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
|
1000000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
6810000 | ||
us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
77774000 | ||
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
184000 | ||
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
11672000 | ||
us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-2649000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-140750000 | ||
us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
-10000 | ||
us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
28000000 | ||
us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
88075000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-2501000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
595000 | ||
us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-288000 | ||
us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
378000 | shares | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
11679000 | ||
us-gaap |
Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
|
-1251000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
100677000 | ||
us-gaap |
Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
|
633000 | ||
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
5426000 | ||
us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
753000 | ||
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-98000 | ||
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
4862000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
25519000 | ||
us-gaap |
Payments For Software
PaymentsForSoftware
|
5329000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
6012000 | ||
us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
938000 | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
98014000 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
30.42 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
29905000 | shares | |
us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
38440000 | ||
us-gaap |
Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
|
-1800000 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
29527000 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
49310 | shares | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
16654000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
328000 | ||
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
26052000 | ||
us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
28000000 | ||
hstm |
Payments To Acquire Cost Method Investments
PaymentsToAcquireCostMethodInvestments
|
1000000 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
HEALTHSTREAM INC | ||
us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
661000 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
42000 | shares | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001095565 | ||
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1516000 | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2016-09-30 | ||
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-42190000 | ||
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1516000 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2016 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
us-gaap |
Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
|
70410000 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.13 | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
15976000 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.13 | ||
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
4109000 | ||
us-gaap |
Costs And Expenses
CostsAndExpenses
|
161149000 | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | ||
us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.380 | pure | |
us-gaap |
Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
|
661000 | ||
us-gaap |
Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
|
661000 | ||
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
791000 | ||
us-gaap |
Sales Revenue Net
SalesRevenueNet
|
167237000 | ||
us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
25396000 | ||
us-gaap |
Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
|
2291000 | ||
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
465000 | ||
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-444000 | ||
us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
43000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
4066000 | ||
us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
82771000 | ||
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
340000 | ||
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
6553000 | ||
us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
6855000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-57617000 | ||
us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
43000 | ||
us-gaap |
Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
|
975000 | ||
us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
53078000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-454000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
326000 | ||
us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
36000 | ||
us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
336000 | shares | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
6088000 | ||
us-gaap |
Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
|
4415000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
444000 | ||
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-1766000 | ||
us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
311000 | ||
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
134000 | ||
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2487000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
14983000 | ||
us-gaap |
Payments For Software
PaymentsForSoftware
|
7070000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
3870000 | ||
us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
846000 | ||
us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
-217000 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
32050000 | shares | |
us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
88197000 | ||
us-gaap |
Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
|
-300000 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
31714000 | shares | |
dei |
Trading Symbol
TradingSymbol
|
HSTM | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
21524000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
94000 | ||
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
27843000 | ||
hstm |
Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
|
3 | Incentive_Plan | |
CY2015Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
26000 | shares |
CY2015Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
440000 | |
CY2015Q3 | us-gaap |
Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
|
23126000 | |
CY2015Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.08 | |
CY2015Q3 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
4639000 | |
CY2015Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.08 | |
CY2015Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
2645000 | |
CY2015Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
49510000 | |
CY2015Q3 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
53835000 | |
CY2015Q3 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
7173000 | |
CY2015Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
28000 | |
CY2015Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
31000 | |
CY2015Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2614000 | |
CY2015Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
4353000 | |
CY2015Q3 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
31000 | |
CY2015Q3 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
386000 | shares |
CY2015Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
4325000 | |
CY2015Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1739000 | |
CY2015Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
32029000 | shares |
CY2015Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
31643000 | shares |
CY2015Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
6195000 | |
CY2015Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
8377000 | |
CY2016Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
21000 | shares |
CY2016Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
512000 | |
CY2016Q3 | us-gaap |
Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
|
24889000 | |
CY2016Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.04 | |
CY2016Q3 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
5755000 | |
CY2016Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.04 | |
CY2016Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
1149000 | |
CY2016Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
57081000 | |
CY2016Q3 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
58367000 | |
CY2016Q3 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
8891000 | |
CY2016Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
337000 | |
CY2016Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-13000 | |
CY2016Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1162000 | |
CY2016Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
1623000 | |
CY2016Q3 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
-13000 | |
CY2016Q3 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
368000 | shares |
CY2016Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1286000 | |
CY2016Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
461000 | |
CY2016Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
32107000 | shares |
CY2016Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
31739000 | shares |
CY2016Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
7261000 | |
CY2016Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
10285000 |